Company intelligence / Profile preview

StressMarq Biosciences

Victoria, British Columbia, Canadastressmarq.com ↗

Ownership: Private
Development stage: Commercial

Overview

StressMarq Biosciences provides validated bioreagents—especially unique fibrillar/oligomeric proteins and antibodies—for global neuroscience and neurodegeneration research. Their products have been widely cited in peer-reviewed literature but are not clinical-stage therapeutics.

Therapeutic areas: Neurology
Modalities: Protein (including monomeric, oligomeric, and fibrillar forms)Antibody (monoclonal and polyclonal)Antibody conjugateSmall moleculeAssay kit (for research use)Recombinant protein
Industry: Non-Drug Biotech

Partnerships

Extensive international distributor network in over 45 countries.

Beyond the preview

Go deeper on StressMarq Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StressMarq Biosciences.

Explore the full profile